94 related articles for article (PubMed ID: 23049204)
1. Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?
Caldwell KE; Conway AP; Hammill CW
Cancer Prev Res (Phila); 2021 Mar; 14(3):373-382. PubMed ID: 33148677
[TBL] [Abstract][Full Text] [Related]
2. Early detection of pancreatic cancer.
Pereira SP; Oldfield L; Ney A; Hart PA; Keane MG; Pandol SJ; Li D; Greenhalf W; Jeon CY; Koay EJ; Almario CV; Halloran C; Lennon AM; Costello E
Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):698-710. PubMed ID: 32135127
[TBL] [Abstract][Full Text] [Related]
3. [Early detection of sporadic pancreatic cancer].
Scherübl H
Z Gastroenterol; 2024 Mar; 62(3):412-419. PubMed ID: 37827502
[TBL] [Abstract][Full Text] [Related]
4. Gaps and Opportunities in the Diagnosis and Treatment of Pancreatic Cancer.
Caban M; Małecka-Wojciesko E
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067280
[TBL] [Abstract][Full Text] [Related]
5. An Overview of Genetic Changes and Risk of Pancreatic Ductal Adenocarcinoma.
Sarnecka AK; Zagozda M; Durlik M
J Cancer; 2016; 7(14):2045-2051. PubMed ID: 27877219
[TBL] [Abstract][Full Text] [Related]
6. Improving early diagnosis of pancreatic cancer in symptomatic patients.
Johnston AJ; Sivakumar S; Zhou Y; Funston G; Bradley SH
Br J Gen Pract; 2023 Dec; 73(737):534-535. PubMed ID: 38035808
[No Abstract] [Full Text] [Related]
7. Corrigendum to "Risk factors for early-onset pancreatic ductal adenocarcinoma: A systematic literature review" [Eur J Cancer 198 (2024) 113471].
Chandana SR; Woods LM; Maxwell F; Gandolfo R; Bekaii-Saab T
Eur J Cancer; 2024 Apr; 201():113941. PubMed ID: 38433045
[No Abstract] [Full Text] [Related]
8. Treating metastatic pancreatic ductal adenocarcinoma: NALIRIFOX as new standard?
Besselink MG; Wilmink JW
Lancet; 2023 Oct; 402(10409):1217-1218. PubMed ID: 37708905
[No Abstract] [Full Text] [Related]
9. Combining prognostic value of serum carbohydrate antigen 19-9 and tumor size reduction ratio in pancreatic ductal adenocarcinoma.
Xia DQ; Zhou Y; Yang S; Li FF; Tian LY; Li YH; Xu HY; Xiao CZ; Wang W
World J Gastrointest Oncol; 2024 Mar; 16(3):798-809. PubMed ID: 38577439
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic pan-RAS Cleavage Leads to Tumor Regression in Patient-derived Pancreatic Cancer Xenografts.
Vidimar V; Park M; Stubbs CK; Ingram NK; Qiang W; Zhang S; Gursel D; Melnyk RA; Satchell KJF
Mol Cancer Ther; 2022 May; 21(5):810-820. PubMed ID: 35247912
[TBL] [Abstract][Full Text] [Related]
11. Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer.
Spano C; Grisendi G; Golinelli G; Rossignoli F; Prapa M; Bestagno M; Candini O; Petrachi T; Recchia A; Miselli F; Rovesti G; Orsi G; Maiorana A; Manni P; Veronesi E; Piccinno MS; Murgia A; Pinelli M; Horwitz EM; Cascinu S; Conte P; Dominici M
Sci Rep; 2019 Feb; 9(1):1788. PubMed ID: 30742129
[TBL] [Abstract][Full Text] [Related]
12. High risk factors of pancreatic carcinoma.
Camara SN; Yin T; Yang M; Li X; Gong Q; Zhou J; Zhao G; Yang ZY; Aroun T; Kuete M; Ramdany S; Camara AK; Diallo AT; Feng Z; Ning X; Xiong JX; Tao J; Qin Q; Zhou W; Cui J; Huang M; Guo Y; Gou SM; Wang B; Liu T; Olivier OET; Conde T; Cisse M; Magassouba AS; Ballah S; Keita NLM; Souare IS; Toure A; Traore S; Balde AK; Keita N; Camara ND; Emmanuel D; Wu HS; Wang CY
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):295-304. PubMed ID: 27376795
[TBL] [Abstract][Full Text] [Related]
13. Implications and issues related to familial pancreatic cancer: a cohort study of hospitalized patients.
Mughetti M; Calculli L; Chiesa AM; Ciccarese F; Rrusho O; Pezzilli R
BMC Gastroenterol; 2016 Jan; 16():6. PubMed ID: 26767414
[TBL] [Abstract][Full Text] [Related]
14. Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model.
Xu HN; Nioka S; Li LZ
Biomark Res; 2013 Jan; 1(1):6. PubMed ID: 24252270
[TBL] [Abstract][Full Text] [Related]
15. Is diabetes mellitus a risk factor for pancreatic cancer?
Pezzilli R; Pagano N
World J Gastroenterol; 2013 Aug; 19(30):4861-6. PubMed ID: 23946590
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic ductal adenocarcinoma screening: new perspectives.
Pezzilli R; Fabbri D; Imbrogno A
World J Gastroenterol; 2012 Sep; 18(36):4973-7. PubMed ID: 23049204
[TBL] [Abstract][Full Text] [Related]
17. Potential biomarkers for early detection of pancreatic ductal adenocarcinoma.
Kriz D; Ansari D; Andersson R
Clin Transl Oncol; 2020 Dec; 22(12):2170-2174. PubMed ID: 32447642
[TBL] [Abstract][Full Text] [Related]
18. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma.
Yu J; Ploner A; Kordes M; Löhr M; Nilsson M; de Maturana MEL; Estudillo L; Renz H; Carrato A; Molero X; Real FX; Malats N; Ye W
Int J Cancer; 2021 Apr; 148(8):2048-2058. PubMed ID: 33411965
[TBL] [Abstract][Full Text] [Related]
19. PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma.
Gold DV; Gaedcke J; Ghadimi BM; Goggins M; Hruban RH; Liu M; Newsome G; Goldenberg DM
Cancer; 2013 Feb; 119(3):522-8. PubMed ID: 22898932
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
